Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

Royalty Pharma plc Director's Dealing 2025

Jul 25, 2025

30286_dirs_2025-07-25_a9a4983c-2aa5-4d03-9dc3-0db208cf4c5f.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Royalty Pharma plc (RPRX)
CIK: 0001802768
Period of Report: 2025-07-17

Reporting Person: Ho Carole (Director)

More from Royalty Pharma plc

Regulatory Filings 2026
May 28
Interim / Quarterly Report 2026
May 6
Regulatory Filings 2026
May 6
Regulatory Filings 2026
Apr 13
Regulatory Filings 2026
Mar 19
Regulatory Filings 2026
Mar 18
Director's Dealing 2026
Mar 4
Director's Dealing 2026
Feb 25
Director's Dealing 2026
Feb 13
Director's Dealing 2026
Feb 13
View all filings →